

Please try another search
Valneva vaccine deal An agreement has been signed granting rights to Valneva’s EB66 cell line for clinical and commercial production of the MVA component of Geovax Labs Inc's (OTC:GOVX)...
Prophylactic potentialGeovax (OTC:GOVX) continues to work with the HIV Vaccine Trials Network (HVTN) to progress development of its lead GOVX-B11 prophylactic HIV vaccine. To date HVTN has conducted...
Prevention is better than cure Geovax Labs Inc (GOVX.PK) prophylactic HIV vaccine is one of the most advanced in development. It can elicit a durable immune response and has been safely administered...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review